Market sizes, forecasts, segment shares, regional analysis, competitive landscape and what it means for buyers, suppliers and investors — triangulated from published research and the Consulting Wallah Network, written by practitioners who run procurement every week. Summaries are free; full reports on request.
Published estimates put the 2025 market at USD 3.6–4.7 bn growing 5–11% a year. Why the range is so wide, what is driving cloud and services, and where the GCC and India opportunity sits.
Read the report →Hospitals & healthcare services · 2026–2032Saudi Arabia and the UAE account for most of GCC healthcare spend; private delivery and mandatory insurance are reshaping who buys what. Country split, capacity pipeline and the implications.
Read the report →Hospitals & healthcare services · 2026–2032The UAE is the GCC’s most private, most insured and most consolidated healthcare market. Where growth is coming from now — and what it takes to sell into it.
Read the report →Hospitals & healthcare services · 2026–2032Saudi Arabia is reorganising the largest healthcare system in the Gulf — clusters, PPPs, a national procurement company and a wave of private capacity. What suppliers and investors need to know.
Read the report →Hospitals & healthcare services · 2026–2032India adds hospital beds faster than any large market, mostly private, increasingly chain-owned. The numbers, the chains and why supply chain is the margin lever.
Read the report →Medical devices · 2026–2032The GCC imports almost all of its medical devices and is now paying suppliers to localise. Market size by country, the registration gates and how tenders are actually won.
Read the report →Medical devices · 2026–2032India is the fourth-largest device market in Asia and still imports most of what it uses. What PLI, device parks and the 2024–25 regulatory changes mean for manufacturers and hospital buyers.
Read the report →Pharmaceuticals · 2026–2032A high-price, originator-heavy market that is pushing generics, local manufacturing and serialisation at the same time. Size, structure and what it takes to register and sell.
Read the report →Pharmaceuticals · 2026–2032Saudi Arabia buys more medicines than any other GCC state and is pushing hard to make them at home. How NUPCO, SFDA and localisation shape who sells what.
Read the report →Pharmaceuticals · 2026–2032India supplies a fifth of the world’s generics by volume and is moving up the value chain into biosimilars and complex generics. Domestic market, exports and what it means for GCC buyers.
Read the report →Pharmaceuticals · 2026–2032Biosimilars are where hospital drug budgets move next: a wave of patent expiries, Indian manufacturers at scale and GCC tenders finally switching. Size, timing and how to capture 40–70% savings.
Read the report →Diagnostics · 2026–2032Lab reagents are one of the largest and least-benchmarked hospital spend lines. GCC market size, the reagent-rental trap and how to tender the bundle.
Read the report →Medical devices · 2026–2032Consumables are a third of hospital supply spend and the easiest category to over-pay in. Market size, the post-pandemic price reset and the commodity tender playbook.
Read the report →Supply chain & logistics · 2026–2032Biologics, GLP-1s and vaccines are turning cold chain into a strategic capability, and most hospital audits still find oxytocin in a warm fridge. Market size and the controls that matter.
Read the report →Digital health · 2026–2032The GCC has built national health information exchanges faster than almost anywhere. Where the money goes next — EMR replacements, virtual care, AI — and how to buy it.
Read the report →Digital health · 2026–2032Saudi Arabia runs the world’s largest virtual hospital and India’s eSanjeevani has delivered hundreds of millions of consultations. Where telehealth is actually making money now.
Read the report →Hospitals & healthcare services · 2026–2032India wins on price and complexity, Dubai on proximity and experience, Turkey and Thailand on volume. The numbers behind medical travel and what hospitals actually need to compete.
Read the report →Hospitals & healthcare services · 2026–2032Hospitals in the Gulf and India are being paid to move care home — long-stay patients, dialysis, infusions, post-surgical recovery. Market size, the licensing rules and the unit economics.
Read the report →Pharmaceuticals · 2026–2032Two chains hold most of Saudi retail pharmacy; a handful of distributors control UAE access. How the channel works, where margins sit and what it means for anyone selling medicines in the Gulf.
Read the report →Payers & insurance · 2026–2032Health insurance is the largest insurance line in the GCC and growing with every mandatory scheme. Premiums, medical inflation and why insurer pressure makes hospital procurement a board issue.
Read the report →Supply chain & logistics · 2026–2032Pooled purchasing saves US hospitals tens of billions a year; the GCC has built national versions and India is starting. What GPOs really deliver, what they cost and how to use one well.
Read the report →Specialty care · 2026–2032Diabetes is filling dialysis chairs across the Gulf and India faster than capacity is built. Market size, the outsourcing models and the consumable contracts that decide cost per session.
Read the report →Pharmaceuticals · 2026–2032Oncology is the largest and fastest-growing drug category, and the one where Indian generics and biosimilars change the economics most. Market size, GCC and India outlook and how to buy.
Read the report →Medical devices · 2026–2032Imaging equipment is the biggest capital line a hospital signs, and the service contract costs more than the scanner. Market size, GCC and India demand, and how to buy on total cost of ownership.
Read the report →Hospitals & healthcare services · 2026–2032Tens of billions of dollars of hospitals are planned or under construction across the Gulf. Where the beds are going, who is building them and when the equipment and supply contracts will be tendered.
Read the report →Published estimates for any market differ by scope and method. Our summaries show the range of published figures and a clearly labelled Consulting Wallah estimate, with sources listed on every report. Want a market sized for a specific decision — a launch, an investment, a tender strategy? Ask for a custom brief.